Efficacy and safety of JMT103 in patients with unresectable or surgically-challenging giant cell tumor of bone: a multicenter, phase Ib/II study.
Xu H, Zhou Y, Liang L, Shen J, Yan W, Wang J, Li J, Zhang X, Huang G, Bi W, Guo Z, Xiao Y, Lin J, Yao W, Tong Z, Zhou W, Zhang G, Ye Z, Wang D, Yang J, Fan Z, Liu C, Qu G, Zhang Q, Wei F, Liu W, Tu C, Li H, Yuan J, Niu X.
Xu H, et al. Among authors: niu x.
Nat Commun. 2024 Nov 5;15(1):9541. doi: 10.1038/s41467-024-53686-4.
Nat Commun. 2024.
PMID: 39500883
Free PMC article.
Clinical Trial.